Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» triple negative breast cancer
triple negative breast cancer
Trovagene Receives Orphan Drug Designation for Onvansertib (PCM-075) for Treatment of Acute Myeloid Leukemia in Europe
CP Wire
Wed, 08/29/18 - 12:42 pm
TrovaGene
Onvansertib
AML
mCRPC
non-Hodgkin lymphoma
triple negative breast cancer
FDA Grants Priority Review and accepts BLA for Sacituzumab Govitecan for the Treatment of Metastatic Triple-negative Breast Cancer
CP Wire
Wed, 07/18/18 - 09:29 am
Immunomedics
FDA
sacituzumab govitecan
triple negative breast cancer
Roche vaults into lead in frontline triple negative breast cancer as Tecentriq/Abraxane combo aces progression-free survival
Endpoints
Mon, 07/2/18 - 09:37 am
Roche
Tecentriq
Genentech
triple negative breast cancer
Celgene
Abraxane
OncoSec to combine ImmunoPulse device with Merck’s immunotherapy in breast cancer trial
Drug Delivery Business News
Tue, 05/8/18 - 11:28 am
OncoSec Medical
Merck
ImmunoPulse IL-12
Keytruda
triple negative breast cancer
Celldex's highly anticipated breast cancer drug fails to hit the mark in a midstage trial
Motley Fool
Mon, 04/16/18 - 09:10 am
Celldex Therapeutics
triple negative breast cancer
glemba
Seattle Genetics chalks up first clinical trial success in solid tumors
Fierce Biotech
Mon, 12/12/16 - 09:22 am
Seattle Genetics
clinical trials
solid tumors
SGN-LIV1A
triple negative breast cancer
Immunomedics Kicked Out of Prestigious ASCO Cancer Conference
TheStreet.com
Fri, 06/3/16 - 09:49 am
Immunomedics
triple negative breast cancer
ASCO 2016
IMMU-132
Roche adds another positive snapshot for its PD-L1 checkpoint star 'atezo'
Fierce Biotech
Fri, 12/11/15 - 11:31 am
atezolizumab
Roche
PD-L1
triple negative breast cancer
Amgen Announces Collaboration With Roche On Cancer Immunotherapy Study With Investigational Medicines Talimogene Laherparepvec And Atezolizumab
Yahoo
Tue, 06/2/15 - 09:15 am
Amgen
Roche
triple negative breast cancer
Talimogene Laherparepvec
atezolizumab
colorectal cancer
Medivation Poised To Expand As Xtandi Shows Efficacy In Advanced Triple Negative Breast Cancer
Seeking Alpha
Wed, 12/17/14 - 08:53 am
Medivation
Xtandi
triple negative breast cancer
breast cancer
Pages
« first
‹ previous
1
2
3